课题基金 / 基金详情

Development of novel therapy against human liposarcoma using siRNAlibrary

Development of novel therapy against human liposarcoma using siRNAlibrary
使用 siRNA 库开发针对人类脂肪肉瘤的新疗法
批准号:
18590349
负责人:
KURODA Masahiko
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KURODA Masahiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The discovery of RNA interference (RNAi) in eukaryotic cells is a major breakthrough in the recent progress of the molecular and cellular biology. RNAi machineries exert biological functions in gene regulation, genome defense, chromatin architecture and dynamics. Today, RNAi has had an enormous impact on the development of novel disease models in animals. In addition, small interfering RNAs (siRNAs), the trigger molecules for RNA silencing, are likely to become invaluable tools for the treatment of various diseases.All of known human myxoid and round cell liposarcomas (MLS/RCLS) are associated with chromosomal translocations. These chromosomal translocations lead to gene fusions that encode chimeric oncoproteins consisting of an N terminus contributed by one of two related genes, TLS (also known as FUS) or EWS, and a C terminus contributed by the CHOP (also called GADD153) gene.In this project, we tried to identify the genes that implicated with tumorigenesis of MLS/RCLS using Lentiviral siRNA library. We infected human myxoid liposarcoma cell lines with Lentiviral siRNA library and we cloned some genes.On the other hand, MicroRNAs (miRNAs) are a family of 21. to 25-nucleotide, noncoding small RNAs that primarily function as gene regulators. MicroRNAs (miRNAs) have been suggested to play important roles in cell proliferation, apoptosis, and differentiation. And aberrant miRNA expression has been described for several human malignancies and tumour suppressor functions have been ascribed to this new class of small regulatory RNAs. Despite this knowledge, there is a lack of information regarding miRNA in the MLS/RCLS. In this project, we have tried to identify downstream miRNA of TLS-CHOP using microarray. And we identified some miRNAthat regulated TLS-CHOP. Interestingly, we transfected some of miRNA that regulated by TLS-CHOP, suppressed tumor growth MLS/RCLS cell lines. These data suggested that some miRNA become drugable target for MLS/RCS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
乳癌におけるG protein-coupled Receptor Kinase 4の腫瘍化能の検討
G 蛋白偶联受体激酶 4 在乳腺癌中致瘤潜力的检查
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Oikawa, K, et. al., 田中 正視, 及川 恒輔, 鈴木 理恵子, Matsubayashi J, Oikawa K, Matsubayashi J, 黒田 雅彦, 松林 純, 及川 恒輔]
通讯作者: 及川 恒輔
Two-dimensional Mapping(pI and m/Z) of Human Serum Using Microchips Combined with MALDI-TOF-MS HUPO
使用微芯片结合 MALDI-TOF-MS HUPO 进行人血清二维绘图(pI 和 m/Z)
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [H, Kawaura, et. al.]
通讯作者: et. al.
子宮内膜症の指標となるHRFの測定系の開発と診断、治療への応用
子宫内膜异位症指标HRF测量系统的开发及其在诊断和治疗中的应用
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [H, Kawaura, et. al., 田中 正視, 徐 明利, 及川 恒輔, 水谷 隆之, 黒田 雅彦, Kawaura H, 及川 恒輔, 徐 明利, 高梨 正勝, Kuroda M, Oikawa K, Morikawa A, Fujita M, 藤田 真知子, 及川 恒輔, 除 明利]
通讯作者: 除 明利
Analysis of the Alternative Spliced Variants of the Essential Gene, hWAPL
必需基因 hWAPL 的选择性剪接变体分析
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Kosuke, Oikawa, et. al.]
通讯作者: et. al.
60
    Analysis of KLF5/4 complex in colon cancer development
    • 批准号:
      25670197
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      KURODA Masahiko
    • 依托单位:
    Novel therapy of myxoid liposarcoma by Chromosome re-programming
    • 批准号:
      23659192
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KURODA Masahiko
    • 依托单位:
    Development of novel cancer therapy using miRNA containing exosome
    • 批准号:
      23390087
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2011
    • 负责人:
      KURODA Masahiko
    • 依托单位:
    Development of novel diagnosis and therapy against human oncogene hWAPL
    • 批准号:
      20390116
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.07万
    • 财政年份:
      2008
    • 负责人:
      KURODA Masahiko
    • 依托单位:
    海外基金